Cargando…
Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis
BACKGROUND: The purpose of this study was to stratify patients with rheumatoid arthritis (RA) according to the trend of disease activity by trajectory-based clustering and to identify contributing factors for treatment response to biologic and targeted synthetic disease-modifying anti-rheumatic drug...
Autores principales: | Koo, Bon San, Eun, Seongho, Shin, Kichul, Hong, Seokchan, Kim, Yong-Gil, Lee, Chang-Keun, Yoo, Bin, Oh, Ji Seon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563490/ https://www.ncbi.nlm.nih.gov/pubmed/36242075 http://dx.doi.org/10.1186/s13075-022-02918-3 |
Ejemplares similares
-
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
por: Koo, Bon San, et al.
Publicado: (2021) -
Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
por: Koo, Bon San, et al.
Publicado: (2015) -
Incidence of rheumatic diseases during the COVID-19 pandemic in South Korea
por: Ahn, Soo Min, et al.
Publicado: (2023) -
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea
por: Ha, So-Young, et al.
Publicado: (2021) -
Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients
por: Nam, So Hye, et al.
Publicado: (2022)